1
|
Hoa S, Milord K, Hudson M, Nicolaidis SC, Bourré-Tessier J. Risk of rheumatic disease in breast implant users: a qualitative systematic review. Gland Surg 2021; 10:2557-2576. [PMID: 34527567 DOI: 10.21037/gs-21-266] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Accepted: 07/23/2021] [Indexed: 11/06/2022]
Abstract
Background Recent studies on the risk of rheumatic disease among breast implant users have reported conflicting results. The primary objective of this study was to provide a systematic and critical review of the literature on the association between breast implants and the risk of rheumatic disease. Methods A qualitative systematic review was conducted in PubMed, MEDLINE, EMBASE, EBM-Reviews and CINAHL Complete from database inception to June 23rd, 2021. Eligible papers were full-length articles in English or French reporting original data on the incident risk of rheumatic disease among individuals with and without breast implants. Data were extracted from published reports and appraised using the Newcastle-Ottawa scale. The main outcome was incident risk of systemic sclerosis (SSc), Sjögren's syndrome (SS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), fibromyalgia and other rheumatic disorders and symptoms. Results Out of 3,425 identified citations, 86 met inclusion criteria. Two cohort studies suggested a two-fold increase in risk of SSc, whereas three case-control studies showed no increase in risk. Three cohort studies did not find an increased risk of incident and confirmed SS among breast implant users, however symptoms of sicca, myalgia and fatigue were reported more frequently. A meta-analysis of heterogenous studies reported a less than two-fold increase in risk of RA. Studies did not support an association with SLE. Insufficient evidence was available for autoimmune myositis and other rheumatic diseases. Implant rupture detected on imaging was not clearly associated with incident rheumatic disease, although no studies specifically examined the risk associated with acute/traumatic rupture. Little data was available on the safety of saline breast implants. Explantation often led to temporary improvement. Conclusions Based on a small number of high-quality and methodologically robust studies, an association between breast implants and a small increase in risk of SSc and RA could not be excluded. Symptoms of sicca, myalgia and fatigue were reported more frequently among breast implant users. Overall, there remains much uncertainty in regard to the association between breast implants and the risk of incident rheumatic diseases. Individuals considering the placement of breast implants should be informed of this uncertainty. Trial Registration This study was registered in the PROSPERO database (#CRD42019133616).
Collapse
Affiliation(s)
- Sabrina Hoa
- Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.,Division of Rheumatology, Department of Medicine, Centre hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada
| | - Kathleen Milord
- Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada
| | - Marie Hudson
- Division of Rheumatology, Department of Medicine, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
| | - Stephen C Nicolaidis
- Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.,Division of Plastic Surgery, Department of Surgery, Centre hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada
| | - Josiane Bourré-Tessier
- Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.,Division of Rheumatology, Department of Medicine, Centre hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada
| |
Collapse
|
2
|
Abstract
Introduction: Although strides have been made to improve breast augmentation surgery, they have focused on the use of single implant devices, necessitating adjustments to the type of operation performed and implants used. And although some breast types obtain excellent results, many others are less than optimal. By developing a thin synthetic expanded polytetrafluoroethylene device, the Pocket Protector, that lines the breast pocket by integrating with the body without a capsule formation, smooth-surfaced gel (or saline) implants can remain soft and provide improved augmentation mammoplasty results. Even patients with Baker class III and IV breasts refractory to all types of revisional surgery can achieve soft, natural breasts after revision with the Pocket Protector. Materials and Methods: Augmentation mammoplasty and revision mammoplasty, often with capsulectomy, with the Pocket Protector was performed on 38 patients with smooth gel or saline implants. Since the initial prototype in April 1995, data have been collected with each patient to evaluate the efficacy of this device. Results: Patients involved in the current study have yielded soft, natural-feeling breasts in the normal anatomic position. Two patients who experienced a flu syndrome in the immediate postoperative period developed refractory seromas necessitating removal of the expanded polytetrafluoroethylene. Both cases have subsequently been successfully revised with Pocket Protectors and smooth-gel implants. Three patients with very thin tissues experienced rippling in spite of using smooth-gel implants. Discussion: The net result yields a soft, ripple-free (or near ripple-free) breast. Additionally, gel implants inside the Pocket Protector are potentially shielded from the body, should the implants rupture. Implants are easily exchangeable if necessary without need for capsulectomy or capsulotomy. The Pocket Protector may also represent an implant device appropriate to treat breasts refractory to traditionally attempted augmentations, such as subcutaneous mastectomy. Although the first case performed in April 1995 has remained successful, most of the experience has been gathered over the past year. This preliminary paper presents the experience with the past 38 cases.
Collapse
|
3
|
Rupture of poly implant prothèse silicone breast implants: an implant retrieval study. Plast Reconstr Surg 2013; 131:480e-489e. [PMID: 23249979 DOI: 10.1097/prs.0b013e3182818a00] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
BACKGROUND Poly Implant Prothèse implants were recalled in Australia in April of 2010 following concerns of higher than expected rupture rates and the use of unauthorized industrial grade silicone as a filler material. Although subsequent investigations found that the gel filler material does not pose a threat to human health, the important question of what caused a relatively modern breast implant to have such a poor outcome compared with contemporary silicone breast implants is yet to be addressed. METHODS From a cohort of 27 patients, 19 ruptured Poly Implant Prothèse breast implants were subjected to a range of mechanical tests and microscopic/macroscopic investigations to evaluate possible changes in properties as a result of implantation. New Poly Implant Prothèse implants were used as controls. RESULTS All samples, explanted and controls, complied with the requirements for shell integrity as specified in the International Organization for Standardization 14607. Compression testing revealed rupture rates similar to those reported in the literature. Shell thickness was highly variable, with most shells having regions below the minimum thickness of 0.57 mm that was specified by the manufacturer. Potential regions of stress concentration were observed on the smooth inner surfaces and outer textured surfaces. CONCLUSIONS The high incidence of Poly Implant Prothèse shell rupture is most likely a result of inadequate quality control, with contributory factors being shell thickness variation and manufacturing defects on both inner and outer surfaces of the shell. No evidence of shell degradation with implantation time was determined.
Collapse
|
4
|
Implant ruptures after augmentation mammoplasty. Aesthetic Plast Surg 2013; 37:60-7. [PMID: 23296758 DOI: 10.1007/s00266-012-0017-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2011] [Accepted: 10/30/2012] [Indexed: 01/14/2023]
Abstract
UNLABELLED This article discusses eleven cases of implant ruptures in nine patients that occurred 3-10 years after primary surgery. The implant ruptures were diagnosed by visual inspection, palpation, ultrasound and MRI of the breast. We describe rupture symptoms and treatment tactics depending on the characteristics of the rupture, the nature of the filler (liquid silicone, soft cohesive gel (Soft Touch™) or high cohesive silicone gel), the current condition of the soft tissues and presence of any complications. We present recommendations allowing early detection of an asymptomatic rupture. LEVEL OF EVIDENCE V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Collapse
|
5
|
Case report: localized scleroderma of the breast after saline implant rupture. EUROPEAN JOURNAL OF PLASTIC SURGERY 2011. [DOI: 10.1007/s00238-010-0447-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
6
|
Capsule formation can make secondary reconstruction of the dura mater unnecessary after cranial infection. J Craniofac Surg 2010; 22:84-8. [PMID: 21187773 DOI: 10.1097/scs.0b013e3181f6c587] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
PURPOSE Defects of the dura mater caused by surgical intervention are often reconstructed using artificial substitutes such as polytetrafluoroethylene membrane (Gore-Tex in commercial name). In cases where secondary infection develops after the initial operation, the artificial substitute used in the primary surgery needs to be removed, and the cranial defect should be covered with tissues abundant in blood supply. The present study discusses the necessity of secondary reconstruction of the dural defect in the recovery operation. METHODS A retrospective study was conducted on 12 patients in whom artificial substitute was exposed because of necrosis of the overlying tissues due to infection or radiation. In recovery operations, the artificial substitute was removed, and the conditions of the underlying defects were evaluated. RESULTS In all cases, capsule formation had developed to cover dural defects underneath the infected artificial substitutes. The capsules were transparent and watertight, presenting no leakage of cerebrospinal fluid. After coverage of the defect regions using free-flap transfer, no patient developed postoperative complications in follow-up periods of at least 6 months. CONCLUSIONS Capsule formation occurs under artificial substitutes after replacement of the dura mater. Because the capsules retain the cerebrospinal fluid, replacement of the artificial materials is unnecessary in the secondary operation.
Collapse
|
7
|
Bassetto F, Vindigni V, Scarpa C, Doria A. Breast prostheses and connective tissue disease (CTD): myth or reality? Aesthetic Plast Surg 2010; 34:257-63. [PMID: 19802514 DOI: 10.1007/s00266-009-9422-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2009] [Accepted: 09/14/2009] [Indexed: 10/20/2022]
Abstract
Since their first appearance, breast prostheses have been criticized as being both responsible for and giving rise to systemic disease. The literature contains many reports on the subject, and theories were controversial from the 1980s to the 2000s. The aim of this review was to gather together the most important studies on breast prostheses and systemic disease, with particular attention to connective tissue disease (CTD), in order to verify any relationship between silicone breast implants and the occurrence of pathologies.
Collapse
|
8
|
Nagasao T, Miyamoto J, Sasaki H, Yazaki T. Capsules can replace the dura mater after cranial infection. Acta Neurochir (Wien) 2010; 152:735-6. [PMID: 19859654 DOI: 10.1007/s00701-009-0547-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2009] [Accepted: 10/12/2009] [Indexed: 11/28/2022]
|
9
|
|
10
|
Chantal M, Melis P, Marco R. SUTURING OF A TEXTURED BREAST IMPLANT FILLED WITH COHESIVE SILICONE GEL TO PREVENT DISLOCATION. ACTA ACUST UNITED AC 2009; 37:236-8. [PMID: 14582758 DOI: 10.1080/02844310310001715] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
We present a case of unilateral anchoring of a style 410 breast implant filled with cohesive silicone gel (McGhan) with four 3/0 braided polyester (Mersilene) sutures. Reoperation after one week and magnetic resonance scanning after six months showed no leakage or bleeding of the prosthesis. Fixation is possible because of the development of cohesive silicone gel in breast implants. Follow up of this patient is necessary for evaluation of long term results.
Collapse
Affiliation(s)
- Mouës Chantal
- Department of Plastic and Reconstructive Surgery, Erasmus MC, Rotterdam, The Netherlands
| | | | | |
Collapse
|
11
|
Wolfram D, Oberreiter B, Mayerl C, Soelder E, Ulmer H, Piza-Katzer H, Wick G, Backovic A. Altered systemic serologic parameters in patients with silicone mammary implants. Immunol Lett 2008; 118:96-100. [PMID: 18462807 DOI: 10.1016/j.imlet.2008.03.007] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2008] [Revised: 03/12/2008] [Accepted: 03/21/2008] [Indexed: 10/22/2022]
Abstract
BACKGROUND The most common local complication in patients with silicone mammary implants (SMIs) is excessive peri-SMI connective tissue capsule formation and its subsequent contracture. However, considerable controversy remains as to whether these implants also cause systemic side effects. The present study was undertaken to identify possible alterations of serological markers in SMI patients that may herald systemic side effects. METHODS We investigated several systemic serological parameters in 143 individuals, 93 of whom had received SMIs and 50 were controls. The patients were grouped according to the severity of capsular contracture (Baker scores I-IV) and the duration of SMI implants (less than 1 year, between 1 and 5 years, more than 5 years). We also included control groups (female blood donors, nurses with possible professional silicone exposure). Patients with breast cancer and subsequent SMI-reconstruction were excluded from the study since they are generally considered immunocompromised. The following parameters were determined: anti-neutrophil cytoplasmatic autoantibodies (cANCA), anti-nuclear autoantibodies (ANA), anti-cardiolipin antibodies (CL-Ab), rheumatoid factor (RF), complement components (C3, C4), circulating immune complexes (CIC), procollagen III (a marker of active fibrosis), anti-polymer antibodies (APA) and soluble intercellular adhesion molecule-1 (sICAM-1). RESULTS The following parameters were increased in the sera of SMI patients: CIC, procollagen III, APA, sICAM-1. CONCLUSIONS We found a set of parameters in serum that correlate with fibrosis development and the duration of the implants in otherwise healthy SMI carriers. Future studies will clarify whether these serological abnormalities will be useful in predicting clinical disease, and also further assess the sensitivity and specificity of these parameters. Our present recommendation as a result of this study is that SMI patients with persistent abnormal serological parameters should be monitored closely by a clinical team that includes rheumatologists.
Collapse
Affiliation(s)
- D Wolfram
- Department of Plastic and Reconstructive Surgery, Innsbruck Medical University, Innsbruck, Austria
| | | | | | | | | | | | | | | |
Collapse
|
12
|
|
13
|
Mosahebi A, Atherton D, Ramakrishnan V. Immediate bilateral autologous breast reconstruction for silicone intolerance. ACTA ACUST UNITED AC 2005; 58:714-6. [PMID: 15925337 DOI: 10.1016/j.bjps.2005.01.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2004] [Accepted: 01/11/2005] [Indexed: 11/16/2022]
Abstract
A one step autologous approach to bilaterally correct recurrent complications of breast reconstruction or augmentation with silicone implants is presented together with five cases. This approach resulted in relief of symptoms with good cosmetic outcome avoiding multiple procedures.
Collapse
Affiliation(s)
- Afshin Mosahebi
- St Andrew's Centre for Plastic Surgery, Broomfield Hospital, Chelmsford, Essex CM1 7ET, UK
| | | | | |
Collapse
|
14
|
Abstract
Capsular contracture, constrictive tightening of scar tissue around implants, was historically the primary reason for reoperating breast-implanted women. Yet, capsular contracture remains of unknown etiology. Contamination with foreign material is one of several suspected causes. Talc, a known fibrogenic agent, was recently found in peri-implant scars. A comparison of 192 explanted women was designed to investigate the role of talc in the induction of capsular contracture. This study included women implanted with silicone gel-filled implants for whom tissue samples were available. Patients were evaluated for the occurrence of capsular contracture and the presence of intracellular talc particles in peri-implant tissues. There was a significant association between talc and capsular contracture (odds ratio = 18.0, 95% confidence interval = 5.9-55, P < 1 x 10(-9)). This study indicates that talc was a major risk factor for capsular contracture in women augmented before 1992.
Collapse
|
15
|
Topping A, George C, Wilson G. Appropriateness of MRI scanning in the detection of ruptured implants used for breast reconstruction. BRITISH JOURNAL OF PLASTIC SURGERY 2003; 56:186-9. [PMID: 12791373 DOI: 10.1016/s0007-1226(03)00031-6] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
This case report highlights the problems associated with ruptured silicone breast implants used for breast reconstructive purposes. The patient originally presented with vague symptoms and signs to her GP and was extensively investigated over a period of years for left-sided chest/abdominal pain. Two separate scanning modalities were used prior to her being seen by either of the main authors and although none were employed specifically to assess for implant rupture, neither detected any free silicone around the hemithorax. The authors suggest that patients who have undergone breast reconstruction with a silicone implant may present in a manner not suggestive of implant damage. In such cases, where the silicone can extend over larger anatomical distances and where side-effects can be damaging the investigation of choice should be MRI scanning which has a greater accuracy for detecting free silicone and defining the extent of spread.
Collapse
|
16
|
Hölmich LR, Kjøller K, Fryzek JP, Høier-Madsen M, Vejborg I, Conrad C, Sletting S, McLaughlin JK, Breiting V, Friis S. Self-reported diseases and symptoms by rupture status among unselected Danish women with cosmetic silicone breast implants. Plast Reconstr Surg 2003; 111:723-32; discussion 733-4. [PMID: 12560693 DOI: 10.1097/01.prs.0000041442.53735.f8] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Epidemiologic evidence does not support an association between silicone breast implants and connective tissue or other rheumatic diseases. However, a recent study has suggested that women with ruptured implants may be at increased risk of developing fibromyalgia. An analysis of adverse health outcomes according to breast implant rupture status was conducted in 238 unselected Danish women with cosmetic silicone breast implants. Ninety-two of the women had definite implant rupture, and 146 had intact implants as determined by magnetic resonance imaging. Before undergoing imaging, the women provided blood samples and completed a self-administered questionnaire. Women with ruptured implants overall, and the subgroup with extracapsular ruptures (n = 23), were compared with women with intact implants regarding a number of self-reported diseases and symptoms and the presence of specific autoantibodies, such as antinuclear antibodies, rheumatoid factor, and cardiolipin immunoglobulin G and M antibodies. Overall, there were no differences in the occurrence of self-reported diseases or symptoms or in the presence of autoantibodies between women with intact implants and women with ruptured implants, including extracapsular rupture. The only exception was capsular contracture, which was reported six times more frequently by women with extracapsular ruptures than by women with intact implants (OR, 6.3; 95 percent CI, 1.7 to 23.5). In conclusion, this study of unselected women with silicone breast implants could establish no association between silicone implant rupture and specific diseases or symptoms related to connective tissue disease or other rheumatic conditions, except for an excess of capsular contracture among women with extracapsular rupture.
Collapse
|
17
|
Puolakkainen P, Bradshaw AD, Kyriakides TR, Reed M, Brekken R, Wight T, Bornstein P, Ratner B, Sage EH. Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials. THE AMERICAN JOURNAL OF PATHOLOGY 2003; 162:627-35. [PMID: 12547720 PMCID: PMC1851143 DOI: 10.1016/s0002-9440(10)63856-4] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
SPARC (secreted protein, acidic and rich in cysteine), a matricellular glycoprotein, modulates the interaction of cells with the extracellular matrix (ECM). Recently, accelerated cutaneous wound closure and altered deposition of collagen were reported in SPARC-null mice. Herein we asked whether SPARC might influence the foreign body reaction to biomaterial implants. Polydimethylsiloxane (silicone rubber) disks and cellulose Millipore filters were implanted into wild-type and SPARC-null mice. In wild-type animals, significant levels of SPARC were observed in the cells and the ECM comprising the capsules around the implants. After 4 weeks, SPARC-null mice exhibited a significant decrease in the thickness of the foreign body capsule, as compared to that observed in wild-type mice. A significant reduction in capsular vascular density was also associated with the silicone implants in the SPARC-null animals. Electron microscopy revealed that collagen fibers in the capsules produced by SPARC-null mice were smaller and more uniform in size than those in wild-type animals. Furthermore, staining with picrosirius-red showed that the collagen fibers were less mature in SPARC-null than in wild-type mice. The altered ECM resulting in decreased capsular thickness, indicative of an altered foreign body reaction in SPARC-null mice, implicates SPARC as an important modulator of the encapsulation of implanted biomaterials.
Collapse
Affiliation(s)
- Pauli Puolakkainen
- Department of Vascular Biology, The Hope Heart Institute, University of Washington, Seattle, Washington 98104, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Eltze E, Bettendorf O, Rody A, Jackisch C, Herchenröder F, Böcker W, Pfleiderer B. Influence of local complications on capsule formation around model implants in a rat model. J Biomed Mater Res A 2003; 64:12-9. [PMID: 12483692 DOI: 10.1002/jbm.a.10342] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
We studied the capsule formation around various filled breast implants and other related changes in distant organs (e.g., liver, spleen, lymph nodes) in a rat model 3 and 6 months after implantation. Model implants, one per rat, (filled with saline, n = 19; silicone, n = 14; cohesive silicone, n = 17; and hydrogel, n = 19) were implanted subcutaneous in the lower back of rats. The animals were sacrificed regularly after 3 and 6 months of implantation or when wound defects occurred. The capsules and organs were examined histologically, and immunohistology of the capsules was performed. A monoclonal antibody specific for AIF-1 (allograft inflammatory factor 1) was used to detect activated macrophages. Wound defects occurred most frequently after implantation of saline and hydrogel implants. Increased capsule thickness was associated with increased grade of inflammation, fibrosis, and the type of implant filling. There was a significant positive correlation between capsule thickness, presence of chronic inflammation, and AIF-1-positive macrophages (p < 0.0001), indicating that inflammation plays an important role in capsule formation. Remarkably, saline and silicone implants (in absence of local complications) cause only a blande slight fibrosis in capsules after 6 months of implantation, whereas capsules around cohesive silicone implants exhibited a more severe fibrosis with an increased capsule thickness. Most importantly, hydrogel seems to be most potent to induce an inflammatory infiltrate with AIF-1 expressing macrophages at the implantation site, independent of implantation time, and capsules also produced a significant increase in thickness after 6 months.
Collapse
Affiliation(s)
- E Eltze
- Gerhard Domagk-Institute of Pathology, University of Muenster, Muenster, Germany
| | | | | | | | | | | | | |
Collapse
|
19
|
Ishimoto SI, Ito K, Toyama M, Kawase I, Kondo K, Oshima K, Niimi S. Vocal cord paralysis after surgery for thoracic aortic aneurysm. Chest 2002; 121:1911-5. [PMID: 12065356 DOI: 10.1378/chest.121.6.1911] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
OBJECTIVE To determine the incidence, etiology, prognosis, and treatment of vocal cord paralysis (VCP) after surgery for thoracic aortic aneurysm (TAA). STUDY DESIGN Retrospective study performed between 1989 and 1995. SETTING Academic, tertiary care, referral medical center. PATIENTS Seventy-one TAA patients underwent surgery at the Kameda Medical Center between 1989 and 1995. RESULTS Sixty-two of 71 patients were examined postoperatively for voice quality. Twenty patients (32%) had hoarseness develop caused by VCP, as confirmed by laryngoscopy. The left recurrent laryngeal nerve had been sacrificed in 1 patient during surgery, but it was preserved in the remaining 19 patients. Unilateral left VCP was noted in 19 patients, and bilateral VCP occurred in 1 patient. The incidence of VCP was higher in those patients who underwent surgery for type I aneurysms (9 of 14 patients, 64%). In 16 of the 19 patients (84%) who received follow-up for > 6 months, vocal cord movement did not return to normal. Surgery to improve voice quality, arytenoid adduction in five patients and intracordal injection in two patients, was performed with success. CONCLUSIONS Our results indicate that surgery for TAA is associated with a relatively high incidence of VCP. VCP occurred despite preservation of the recurrent laryngeal nerve, and the paralysis did not show a spontaneous recovery even 6 months after surgery.
Collapse
Affiliation(s)
- Shin-Ichi Ishimoto
- Department of Otolaryngology, Faculty of Medicine, University of Tokyo, Tokyo
| | | | | | | | | | | | | |
Collapse
|
20
|
Coon SK, Burris R, Coleman EA, Lemon SJ. An analysis of telephone interview data collected in 1992 from 820 women who reported problems with their breast implants to the food and drug administration. Plast Reconstr Surg 2002; 109:2043-51. [PMID: 11994612 DOI: 10.1097/00006534-200205000-00040] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
How health care providers deal with concerns and feelings of women who have problems with their breast implants affects the women's satisfaction with their breast implants, yet in 1992 little was known about the concerns and feelings of these women. A qualitative analysis of in-depth telephone interviews conducted in 1992 with 820 women from all regions of the United States who reported problems with their breast implants to the Food and Drug Administration and responded to an invitation to be interviewed provided data. Respondents were primarily 40 to 69 years of age at the time of interview, Caucasian, married, and educated beyond high school. The sample was almost equally divided in reason for breast implants, with 65 percent being dissatisfied with their breast implants. Nearly all of the women had heard of problems with silicone gel-filled implants. Their main sources of information were television, newspapers, and magazines rather than their physicians or the breast implant manufacturers. Some women tried to avoid hearing the reports, and many tried to put the reported problems out of their minds. However, a majority (88.7 percent) wanted more information. The women expressed feelings of anger, regret, and worry, and repeatedly said they needed more information. Women who contacted the Food and Drug Administration about breast implant problems needed accurate and honest information from health care professionals. They wanted their physicians to explore their symptoms, fears, and concerns.
Collapse
Affiliation(s)
- Sharon K Coon
- College of Nursing, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205-7199, USA
| | | | | | | |
Collapse
|
21
|
Whitlock PW, DeAnglis AP, Ackley KL, Clarson SJ, Retzinger GS. Distribution of silicon/e in tissues of mice of different fibrinogen genotypes following intraperitoneal administration of emulsified poly(dimethylsiloxane) [correction of poly(dimethysiloxane)]. Exp Mol Pathol 2002; 72:161-71. [PMID: 11890725 DOI: 10.1006/exmp.2002.2422] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Following injection into the abdominal cavity of a C57BL/6 mouse, droplets of emulsified PDMS visible by light microscopy (diameter > or = 1 microm) disseminate to multiple organs of the animal. Because fibrinogen may facilitate dissemination, we compared histologically the accumulation of PDMS droplets in lymph nodes, lungs, spleen, liver, and left kidney of Fib +/+, Fib +/-, and Fib -/- mice of C57BL/6 background 35 and 75 days after intraperitoneal injection of an emulsion of the polymer. We also used ICP-AES to assess the accumulation of silicon in the lymph nodes, livers, and spleens of the animals. The emulsion droplets ranged in diameter from approximately 0.04 to approximately 80 microm. PDMS droplets visible by light microscopy were in all organs of both Fib +/+ mice and Fib +/- mice. In those animals, droplets were invariably either within or adjacent to inflammatory cells, predominantly macrophages. In contrast, PDMS droplets were visible in none of the organs of Fib -/- mice. Despite the absence of visible droplets in them, the lymph nodes, livers, and spleens of Fib -/- mice, like the corresponding organs of Fib +/+ and Fib +/- mice, contained measurable silicon after 35 and 75 days. The amount of silicon, however, was always greater in the organs of Fib +/+ and Fib +/- mice than in the organs of Fib -/- mice. We attribute the presence of silicon in organs that had no histologic evidence of droplets to diffusion of the very smallest droplets/soluble species of PDMS from the abdominal cavity. Taken together, our data and observations implicate a role for fibrinogen in the dissemination of larger PDMS droplets in vivo. We propose this role involves recognition of droplet-bound fibrinogen by macrophages and, perhaps, other inflammatory cells, and the subsequent fibrinogen-facilitated ingestion and/or extracellular movement of the droplets by those cells.
Collapse
Affiliation(s)
- Patrick W Whitlock
- Department of Materials Science and Engineering and the Polymer Research Center, University of Cincinnati, Cincinnati, OH 45267-0529, USA
| | | | | | | | | |
Collapse
|
22
|
Abstract
LEARNING OBJECTIVES After studying this article, the participant should: 1. Be familiar with the medical uses of silicone. 2. Have a working knowledge of the most important epidemiologic studies regarding silicone gel-filled breast implants. 3. Be aware of the issues about which patients desiring breast augmentation or reconstruction with implants must be counseled.
Collapse
Affiliation(s)
- A R Muzaffar
- Department of Plastic and Reconstructive Surgery, University of Texas Southwestern Medical Center, Dallas, 75390-9132, USA
| | | |
Collapse
|
23
|
Sarwer DB, Nordmann JE, Herbert JD. Cosmetic breast augmentation surgery: a critical overview. JOURNAL OF WOMEN'S HEALTH & GENDER-BASED MEDICINE 2000; 9:843-56. [PMID: 11074950 DOI: 10.1089/152460900750020874] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Despite the ban on silicone gel breast implants in 1992, the last decade witnessed a dramatic increase in the number of cosmetic breast augmentation procedures performed in the United States. According to the American Society of Plastic Surgeons, over 132,000 women in this country underwent the procedure in 1998. This is an underestimate of the actual number of breast augmentations performed annually, as increasing numbers of nonsurgeon physicians are now performing cosmetic surgery. Given the rising number of women who now seek cosmetic breast augmentation surgery, it is likely that women's healthcare providers will be asked by their patients about breast augmentation. This review is designed to provide an overview of the medical and psychological literature on cosmetic breast augmentation. We begin with a history of breast augmentation, including an overview of the controversy of silicone breast implants and the Institute of Medicine's report on their safety published in 1999. We also discuss the psychological characteristics of breast augmentation patients, reviewing both preoperative and postoperative studies. We conclude with suggestions for future research as well as a discussion of the clinical relevance of this area for women's healthcare professionals.
Collapse
Affiliation(s)
- D B Sarwer
- Department of Psychiatry and Surgery, Edwin and Fannie Gray Hall Center for Human Appearance, University of Pennsylvania School of Medicine, Philadelphia 19104, USA
| | | | | |
Collapse
|
24
|
Mera S, Santoyo J, Suárez MA, Bondía JA, Cabello AJ, Jiménez M, Ribeiro M, Fernández-Aguilar JL, Pérez-Daga JA, de La Fuente A. Use of the breast implant for liver graft malposition. LIVER TRANSPLANTATION AND SURGERY : OFFICIAL PUBLICATION OF THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES AND THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY 1999; 5:534-5. [PMID: 10545544 DOI: 10.1002/lt.500050604] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Transplantation of a small liver into a large patient may cause problems with correct reperfusion of the graft because of torsion of the hepatic pedicle, leading to malfunction of the transplanted organ. We describe the case of a 60-year-old man with alcoholic cirrhosis and hepatitis B virus who received a small-sized liver graft. Owing to the lack of adequate reperfusion of the transplanted organ arising from pedicular kinking caused by disparate sizes, a breast implant was placed behind the graft as a means of support, thereby resolving the problem. The use of prosthetic materials for the correct placement of grafts with size incongruity is also discussed, and the literature is reviewed.
Collapse
Affiliation(s)
- S Mera
- Department of General and Digestive Surgery, Unit of Hepato-pancreato-biliary Surgery and Liver Transplantation, Carlos Haya Regional University Hospital, Málaga, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|